216 related articles for article (PubMed ID: 24442715)
41. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
[TBL] [Abstract][Full Text] [Related]
42. Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma).
Scheja A; Akesson A
Clin Exp Rheumatol; 1997; 15(3):283-8. PubMed ID: 9177923
[TBL] [Abstract][Full Text] [Related]
43. [Initial visceral involvement with diffuse systemic scleroderma].
Gruschwitz MS; Steffan C; Albrecht HP; Hornstein OP
Hautarzt; 1994 Nov; 45(11):787-91. PubMed ID: 7822206
[TBL] [Abstract][Full Text] [Related]
44. Gelatinases Increase in Bleomycin-induced Systemic Sclerosis Mouse Model.
Vafashoar F; Mousavizadeh K; Poormoghim H; Tavasoli A; Musavi Shabestari T; Javadmoosavi SA; Mojtabavi N
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):182-189. PubMed ID: 31066254
[TBL] [Abstract][Full Text] [Related]
45. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study.
Foocharoen C; Thinkhamrop B; Mahakkanukrauh A; Suwannaroj S; Netwijitpan S; Sripavatakul K; Chuealee W; Boottam B; Towiwat P; Seubmee P; Daungkum K; Kongpan D; Mangkala J; Nanagara R
J Med Assoc Thai; 2015 Nov; 98(11):1082-8. PubMed ID: 26817178
[TBL] [Abstract][Full Text] [Related]
46. Audio frequency in vivo optical coherence elastography.
Adie SG; Kennedy BF; Armstrong JJ; Alexandrov SA; Sampson DD
Phys Med Biol; 2009 May; 54(10):3129-39. PubMed ID: 19420415
[TBL] [Abstract][Full Text] [Related]
47. Quantitative Assessment of Skin Stiffness in Localized Scleroderma Using Ultrasound Shear-Wave Elastography.
Wang L; Yan F; Yang Y; Xiang X; Qiu L
Ultrasound Med Biol; 2017 Jul; 43(7):1339-1347. PubMed ID: 28457631
[TBL] [Abstract][Full Text] [Related]
48. Localized cutaneous fibrosing disorders.
Yaqub A; Chung L; Rieger KE; Fiorentino DF
Rheum Dis Clin North Am; 2013 May; 39(2):347-64. PubMed ID: 23597968
[TBL] [Abstract][Full Text] [Related]
49. N-TproBNP as biomarker in systemic sclerosis.
Schioppo T; Artusi C; Ciavarella T; Ingegnoli F; Murgo A; Zeni S; Chighizola C; Meroni PL
Clin Rev Allergy Immunol; 2012 Dec; 43(3):292-301. PubMed ID: 22669751
[TBL] [Abstract][Full Text] [Related]
50. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
51. Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis.
Müller B; Ruby L; Jordan S; Rominger MB; Mazza E; Distler O
Arthritis Res Ther; 2020 Jun; 22(1):128. PubMed ID: 32493508
[TBL] [Abstract][Full Text] [Related]
52. [The clinical picture of morphea].
Wojas-Pelc A; Wielowieyska-Szybińska D
Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
[TBL] [Abstract][Full Text] [Related]
53. Emerging targeted therapies in scleroderma lung and skin fibrosis.
Maurer B; Distler O
Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):843-58. PubMed ID: 22265265
[TBL] [Abstract][Full Text] [Related]
54. [Scleroderma].
Distler O; Gay S
Internist (Berl); 2010 Jan; 51(1):30-8. PubMed ID: 20033389
[TBL] [Abstract][Full Text] [Related]
55. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
[TBL] [Abstract][Full Text] [Related]
56. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
57. Reassessing the Role of the Active TGF-
Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
[No Abstract] [Full Text] [Related]
58. [Sclerosing skin diseases].
Sticherling M
Internist (Berl); 2019 Aug; 60(8):783-791. PubMed ID: 31292667
[TBL] [Abstract][Full Text] [Related]
59. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
